Improving the efficiency and effectiveness of pragmatic clinical trials in older adults in the United States

Abstract

Pragmatic clinical trials (PCTs) seek to improve the generalizability and increase the statistical power of traditional explanatory trials. They are a major tenet of comparative effectiveness research. While a powerful study design, PCTs have been limited by high cost, modest efficiency, and limited ability to fill relevant evidence gaps. Based on an American Reinvestment and Recovery Act (ARRA) supported meeting of national stakeholders, we propose several innovations and future research that could improve the efficiency and effectiveness of such studies focused in the U.S. Innovations discussed include optimizing the use of community based practices through partnership with Practice Based Research Networks (PBRNs), using information technology to simplify PCT subject recruitment, consent and randomization processes, and utilizing linkages to large administrative databases, such as Medicare, as a mechanism to capture outcomes and other important PCT variables with lower subject and research team burden. Testing and adaptation of such innovations to PCT are anticipated to improve the public health value of these increasingly important studies.

Comparative effectiveness of a bioengineered living cellular construct vs. a dehydrated human amniotic membrane allograft for the treatment of diabetic foot ulcers in a real world setting

“…High‐quality observational research can determine comparative effectiveness and address some of the uncertainty that exists regarding the effects of treatments on patient outcomes to limit overuse of ineffective therapies and underuse of effective therapies . Real‐world comparative effectiveness studies are often necessary to answer important questions about particular populations and conditions as they use active comparators and employ broad inclusion criteria to evaluate large and diverse patient populations that are representative of those treated in routine practice . Typical RCTs determine efficacy, that is, whether a product can work in a controlled setting.…”

Prognostic and Therapeutic Implications of Frailty in Older Adults with Heart Failure

“…Pragmatic randomized trials [50] that enlist frail patients are needed to determine the effects of guideline-based HF therapy on survival, hospitalizations, adverse drug events, and equally important-on patient-centered outcomes pertaining to physical functioning and quality of life. These trials may Fig.…”

Individualized patient decision-aid for immunosuppressive drugs in women with lupus nephritis: study protocol of a randomized, controlled trial

“…Patients will rate the quality and the quantity of the information presented in decision aids (4-point scale ranging from “excellent” to “poor”) and rate the appropriateness of amount of information (responder burden), presentation style and usefulness. Feasibility will be assessed by the amount of assistance required in navigating decision aids (none, a little, some, a lot) and with a self-administered satisfaction questionnaire [ 63 ]. Patients will rate satisfaction with decision aids on a 5-point Likert scale ranging from strongly agree to strongly disagree: Easy to use, practical, process did not take too long, easy to understand, did not mind spending extra time.…”